140 related articles for article (PubMed ID: 27146715)
1. Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine.
Suzuki T; Aoyama T; Suzuki N; Kobayashi M; Fukami T; Matsumoto Y; Tomono K
Biopharm Drug Dispos; 2016 Sep; 37(6):323-35. PubMed ID: 27146715
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.
Suzuki T; Fukami T; Tomono K
Biopharm Drug Dispos; 2015 Mar; 36(2):126-37. PubMed ID: 25410756
[TBL] [Abstract][Full Text] [Related]
3. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
Okura T; Higuchi K; Kitamura A; Deguchi Y
Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
[TBL] [Abstract][Full Text] [Related]
4. Memantine transport across the mouse blood-brain barrier is mediated by a cationic influx H+ antiporter.
Mehta DC; Short JL; Nicolazzo JA
Mol Pharm; 2013 Dec; 10(12):4491-8. PubMed ID: 24098999
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.
Kurosawa T; Higuchi K; Okura T; Kobayashi K; Kusuhara H; Deguchi Y
J Pharm Sci; 2017 Sep; 106(9):2576-2582. PubMed ID: 28454746
[TBL] [Abstract][Full Text] [Related]
7. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
8. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
9. Transport of amantadine and rimantadine through the blood-brain barrier.
Spector R
J Pharmacol Exp Ther; 1988 Feb; 244(2):516-9. PubMed ID: 3346834
[TBL] [Abstract][Full Text] [Related]
10. Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs.
André P; Debray M; Scherrmann JM; Cisternino S
J Cereb Blood Flow Metab; 2009 Jul; 29(7):1293-304. PubMed ID: 19458607
[TBL] [Abstract][Full Text] [Related]
11. The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.
Svane N; Pedersen ABV; Rodenberg A; Ozgür B; Saaby L; Bundgaard C; Kristensen M; Tfelt-Hansen P; Brodin B
Fluids Barriers CNS; 2024 May; 21(1):39. PubMed ID: 38711118
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.
Cisternino S; Chapy H; André P; Smirnova M; Debray M; Scherrmann JM
AAPS J; 2013 Apr; 15(2):299-307. PubMed ID: 23212563
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the H+/organic cation antiporter in nicotine transport in rat liver.
Tega Y; Akanuma S; Kubo Y; Hosoya K
Drug Metab Dispos; 2015 Jan; 43(1):89-92. PubMed ID: 25352656
[TBL] [Abstract][Full Text] [Related]
14. Blood-to-brain influx transport of nicotine at the rat blood-brain barrier: involvement of a pyrilamine-sensitive organic cation transport process.
Tega Y; Akanuma S; Kubo Y; Terasaki T; Hosoya K
Neurochem Int; 2013 Jan; 62(2):173-81. PubMed ID: 23228345
[TBL] [Abstract][Full Text] [Related]
15. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
[TBL] [Abstract][Full Text] [Related]
16. Carrier-Mediated Transport of Nicotine Across the Inner Blood-Retinal Barrier: Involvement of a Novel Organic Cation Transporter Driven by an Outward H(+) Gradient.
Tega Y; Kubo Y; Yuzurihara C; Akanuma S; Hosoya K
J Pharm Sci; 2015 Sep; 104(9):3069-75. PubMed ID: 25892000
[TBL] [Abstract][Full Text] [Related]
17. Pyrilamine-sensitive proton-coupled organic cation (H
Wang X; Qi B; Su H; Li J; Sun X; He Q; Fu Y; Zhang Z
J Control Release; 2017 May; 254():34-43. PubMed ID: 28351667
[TBL] [Abstract][Full Text] [Related]
18. [The blood-brain barrier transport mechanism controlling analgesic effects of opioid drugs in CNS].
Okura T; Higuchi K; Deguchi Y
Yakugaku Zasshi; 2015; 135(5):697-702. PubMed ID: 25948304
[TBL] [Abstract][Full Text] [Related]
19. Involvement of an influx transporter in the blood-brain barrier transport of naloxone.
Suzuki T; Ohmuro A; Miyata M; Furuishi T; Hidaka S; Kugawa F; Fukami T; Tomono K
Biopharm Drug Dispos; 2010 May; 31(4):243-52. PubMed ID: 20437463
[TBL] [Abstract][Full Text] [Related]
20. The involvement of a Na⁺- and Cl⁻-dependent transporter in the brain uptake of amantadine and rimantadine.
Kooijmans SA; Senyschyn D; Mezhiselvam MM; Morizzi J; Charman SA; Weksler B; Romero IA; Couraud PO; Nicolazzo JA
Mol Pharm; 2012 Apr; 9(4):883-93. PubMed ID: 22352408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
